bone tumor; children; expendable prostheses; leg length Background/Purpose: In limb reconstruction following resection of malignant bone tumors in children, extendable prostheses are considered to be useful since future leg length correction can be controlled. We evaluated the usefulness of extendable prostheses in 11 such cases. Methods: The study included 11 children aged 7e16 years (mean 11 years) who underwent limb reconstruction using an extendable prosthesis between 1994 and 2008. The follow-up period varied from 1 to 16 years (mean 6 years and 2 months). Nine patients had osteosarcoma, one had a primitive neuroectodermal tumor (PNET) and one had Ewing's sarcoma. The tumor was located in the distal femur, (n Z 6), proximal femur (n Z 1), or proximal tibia (n Z 4). Functional scores, X-ray images, the number of lengthening procedures, total length gain, complications, and leg length discrepancy were recorded for each patient. Results: The functional scores range from 52% to 96% (mean 84%). X-Ray evaluation revealed fair and poor bone remodeling in three patients each. The mean number of elongation procedures was 2.8 and the mean total length gain was 49.7 mm. The final leg length discrepancy was 29.2 mm. Conclusion: Extendable bone prostheses are useful for reconstruction. According to our experience, this method is indicated in children of at least 10 years of age for whom a future leg-length discrepancy of up to 4 cm is expected and who have a lesion located in the distal femur where the prosthesis can be adequately covered by soft tissue.
In limb reconstruction following resection of malignant bone tumors in children, physis loss affects anticipated leg-length discrepancy. Therefore, joint function should be preserved to the maximum extent possible and reconstruction assuring permanent good function of the affected limb should be carried out. In particular, extendable prostheses are considered to be useful for reconstruction in children with malignant bone tumors to allow future correction of leglength discrepancy. 1e8 In cooperation with the Japanese Musculoskeletal Oncology Group (JMOG), we previously studied short-term results obtained with extendable prostheses in 28 patients in Japan, and confirmed their usefulness. 9 In our department, 11 patients have undergone reconstruction of an affected limb using an extendable prosthesis, and some have been followed up for more than 10 years. However, problems associated with extendable prostheses have arisen. Therefore, we present our treatment results, indications for extendable prostheses, and a brief review of the literature.
Patients and methods
The patients were 11 children with a malignant bone tumor of the lower limb who underwent reconstruction with an extendable prosthesis at our department between 1994 and 2008. They ranged in age from 7 to 16 years (mean 11 years). The follow-up period was 1e16 years (mean 6 years and 2 months). The Enneking surgical stage was IIB in all patients. The histopathological diagnosis was osteosarcoma in nine patients, primitive neuroectodermal tumor (PNET) in one patient and Ewing's sarcoma in one patient. The tumor was located in the distal femur in six patients, in the proximal femur in one patient, and in the proximal tibia in four patients.
Adjuvant therapy
For osteosarcoma cases, we used the following pre-and postoperative chemotherapy protocol, developed in cooperation with the Department of Pediatrics, for localized tumors not accompanied by metastasis at the time of initial consultation. 10 This protocol consists of two courses of regimen A and two courses of regimen B, followed by surgery and two postoperative courses of regimens C þ B þ B and two courses of regimens A þ B þ B. 
Surgery
The resection margins were determined by diagnostic imaging according to the criteria of Kawaguchi et al. 11 In all patients, extensive resection with a margin 3 cm was performed.
Extendable prostheses
A growing Kotz type prosthesis was used in six patients who underwent distal femur replacement and four who underwent proximal tibia replacement. The component and stem were unified in all of these prostheses. A Lewis type prosthesis was used in one patient who underwent proximal femur replacement. All prostheses were custom-made and had been designed after determining the resection range by diagnostic imaging following a single course of preoperative chemotherapy. Growth was predicted based on the Anderson and Green growth prediction curve. 12 Since the Lewis type prosthesis has not been approved by the insurance system in Japan, this type was used only for patients who imported it after approval from both the hospital and the patient's family was obtained (Table 1) . Functional evaluations were performed according to the International Symposium of Limb Salvage (ISOLS) system, 13 as well as X-ray evaluation 14 and assessment of details (such as stem size and length) of the extendable prosthesis, number of elongation procedures, length gain, present leg length discrepancy, complications, and outcome. We used these data to analyze the advantages and disadvantages of extendable prostheses after resection of malignant bone tumors in children. DF Z distal fibula; PF Z proximal fibula; PNET Z primitive neuroectodermal tumor; PT Z proximal tibia.
Results

Functional evaluation
Functional evaluations were performed according to the ISOLS system in terms of pain, function, supports, walking, and gait. Emotional acceptance was excluded because questions asked of children regarding the degree of satisfaction tend to be leading, which can make objective evaluation difficult. The functional score ranged from 52% to 96% (mean 84%). Patient 11, with a score of 52%, had an osteosarcoma in the proximal tibia and received walking training using a knee orthosis after surgery, but developed lung metastasis approximately 3 months after the operation and died around 12 months postoperatively. Patients 3, 5, 6 and 7, with scores 90%, had osteosarcoma of the distal femur ( Table 2 ).
X-Ray evaluation
X-Ray evaluation was performed using the ISOLS system at the time of final consultation. Bone remodeling results were excellent in five patients, fair in three patients, and poor in three patients. The three patients with poor results (Patients 1, 2 and 8) showed no clinical symptoms such as pain during walking. The interface result was poor in three patients, fair in one patient and good in one patient. In terms of anchorage, fracture of the screw for plate fixation was observed only in Patient 4. However, since there was no loosening, the result was regarded as fair (Table 2) .
Stem length and thickness
The stem diameter on the femoral side was 8e11 mm (mean 10.1 mm). Length was determined by measuring from the stem base to tip of the component and was 80e110 mm (mean 95.1 mm). The stem diameter on the tibial side was 10e11 mm (mean 10.5 mm). The length was 100 mm in all patients. The amount of bone resected was 130e200 mm (mean 114 mm) on the femoral side and 100e160 mm (mean 132.5 mm) on the tibial side (Table 2) .
Anticipated bone growth and present leg-length discrepancy
The mean anticipated bone growth was 42.9 mm (range 26e86 mm). The mean number of elongating procedures was 2.8 (range 1e5). Planned lengthening was completed in only Patients 2, 5 and 6. Elongation was performed via a small incision made under general anesthesia in all patients. The amount of lengthening obtained per surgical elongation procedure was 11.5 mm (range 8.6e13.6 mm). Leg length discrepancy at the time of final consultation ranged from 10 mm to 45 mm (mean 29.2 mm). Patient 2 (a 7-year-old female) with PNET of the distal femur who underwent five elongation procedures was the first in whom an extendable prosthesis was used in our department. The total length gain was 43.5 mm, but revision surgery was performed owing to loosening around the tibial component. At present, the leg length discrepancy is 45 mm. Patient 1 was an 11-year-old female in whom a Lewis type extendable prosthesis was used for the proximal femur. She underwent two elongation procedures and the total length gain was 35 mm. However, the leg length discrepancy is still 40 mm. Patient 6, with a sarcoma of the distal femur, underwent three elongation procedures. Although the planned length gain was achieved, he, like Patient 2, still has a substantial leg length discrepancy of 41 mm (Table 3) .
Complications
Sinking of the tibial stem due to stem loosening was observed in two patients, one of whom underwent revision surgery. Patient 2 showed stem loosening 7 years after the operation and underwent revision surgery 9 years and 5 months after the initial surgery. Patient 6 showed similar findings 1 year after the operation, but has been followed up without further intervention as he does not experience any disruption to daily living activities. Patient 8 showed stem loosening around the tibial stem 18 months after wide resection. He ultimately underwent an above-knee amputation because of infection. Patient 8 was an 8-year-old male with a tibial osteosarcoma. Wound swelling was observed after the operation, and conservative treatment involving postoperative chemotherapy was administered. However, his symptoms did not improve, so lavage and debridement were performed 18 months after the operation. Since the wound infection did not subside, he underwent an above-knee amputation. Patient 10 was a 12-year-old female with tibial osteosarcoma. She showed postoperative wound hematoma and underwent debridement 3 weeks after the operation, which resulted in symptom improvement. None of our patients showed stem breakage.
Outcomes
Patients 9 and 11 died of lung metastasis. The other patients have remained disease-free to date.
Discussion
The methods for limb reconstruction after resection of malignant bone tumors in children vary according to the site of resection. When diaphyseal lesions are resected, the affected limb is reconstructed using vascularized fibular flaps, 15 distraction osteogenesis, 16 the autoclave method, 17 or extracorporeal irradiation 18 if the joint can be preserved in the metaphysis. However, if joint preservation is impossible due to resection of an extensive area including the epiphysis, tumor type or extendable prostheses are used. In patients showing tumor invasion into blood vessels or nerve fascicles in whom safety margins are difficult to obtain, reconstruction methods such as rotation plasty 19 are indicated for preservation of the affected limb, so that amputation can be avoided. Whichever method is selected, limb reconstruction is required to obtain a useful limb in the future and leg length discrepancy must then be considered. Extendable prostheses are used when periarticular tumors are resected together with the joint. Scales and Sneath are considered to have been the first to develop extendable prostheses, in 1976. 4 In 1986, Lewis used extendable prostheses in six children with malignant bone tumors in the USA. 2 In 1992, Kotz et al developed an extendable prosthesis that can be replaced by a Howmedica modular reconstruction system (HMRS) after growth. 1, 5 In 1998, Schindler developed a custom-made Stanmore extendable prosthesis and used it in six patients aged 2e12 years with primary malignant bone tumors. 6 Extendable prostheses are indicated in patients approximately 10 years of age with periarticular bone tumors in whom a leg length discrepancy of no more than 4 cm is expected in the future. The extension mechanism of extendable prostheses is classified into the invasive type requiring minor surgery and the noninvasive type in which the extension mechanism is induced by application of, for example, an extracorporeal system. The extension mechanism of the growing Kotz prosthesis is classified as invasive. The part designed for extension is loosened by rotating the rocking screw and can be extended by 0.9 mm by adjusting the screw one turn to the left. The diaphyseal fixation piece of the part for extension is porous-coated, while the non-extension part is non-porous. The growing Kotz prosthesis allows extension with growth and can be replaced by an HMRS after growth completion. 1, 5, 9 Tumor type prostheses with a noninvasive extension system have also been developed. In 2003, Neel et al reported results for a multicenter study of the Phenix extendable prosthesis, used as a noninvasive prosthesis in 18 patients. 20 An annular electromagnetic coil compressed using a locking system is extended by applying an extracorporeal system, which results in extension of the entire joint prosthesis. Baumgart et al developed a bio-expandable prosthesis in 2005 and reported on the MUTARS Xpand expandable tumor prosthesis in 2009. 8 This expandable prosthesis has a mortar device in its main portion for extension. These prostheses are still in the development stage. To establish a stable extension mechanism, more time may be necessary.
In our experience, the main problems with extendable prostheses are: (1) age indicated for the prosthesis; (2) loosening; and (3) infection. The age indicated for extendable prostheses is 7e14 years (mean 10.1 years) in the literature, although we found that 7e16 years (mean 11 years) was appropriate in the present survey. Thus, the appropriate age is approximately 10 years. If growth of approximately 4 cm is expected based on the Anderson and Green growth prediction curves, and age at the time of extension completion to be w18 years, an age of 12e13 years (at least 10 years) is appropriate for extendable prostheses. 21, 22 There are no effective measures against loosening at present. We observed loosening due to the extension mechanism of the growing Kotz prosthesis. In two patients who underwent replacement of the distal femur, clear loosening was observed around the stem of the tibial component. One of these patients underwent revision surgery. The stem of the tibial component for the growing Kotz prosthesis for the distal femur has a nonporous coating. The entire component is lifted with tibial growth after preservation of the tibial diaphysis, which is useful for leg length correction and facilitates replacement with conventional tibial components. However, in young children, since actual bone growth is difficult to predict, this component mechanism may sometimes cause loosening. To prevent loosening, design of the component should take into consideration growth in the tibial transverse diameter, and replacement surgery should be planned soon after limitations in the range of knee motion or pain during walking are reported. Wound infection did not subside in one of our four patients with a tibial proximal bone tumor, and amputation was necessary. In this patient, the growing Kotz prosthesis for the proximal tibia was too large for the tibial resection area, and wound closure was difficult in the first operation, which may have caused infection. For use of an extendable prosthesis in the proximal tibia, proper evaluation of the patient's physique is required because the soft tissue volume is small.
Extendable prostheses are indicated in Japanese children of 10 or more years of age. The optimal age is 12 or 13 years because growth has been completed by the time lengthening is complete. The distal femur, with adequate soft tissue covering the entire prosthesis, is the most appropriate site.
In limb reconstruction after resection of malignant bone tumors in children, extendable prostheses can be extended with growth while taking the expected future leg-length discrepancy into consideration. However, length gain is limited, and the age and area indicated for these prostheses should be adequately evaluated. From our experience, the optimal candidates for an extendable prosthesis are children at least 10 years of age with bone tumors in the distal femur, where the prosthesis can be adequately covered by soft tissue.
